These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20620183)

  • 1. Bioneedles as alternative delivery system for hepatitis B vaccine.
    Hirschberg HJ; van de Wijdeven GG; Kraan H; Amorij JP; Kersten GF
    J Control Release; 2010 Oct; 147(2):211-7. PubMed ID: 20620183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
    Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioneedles as vaccine carriers.
    Hirschberg HJ; van de Wijdeven GG; Kelder AB; van den Dobbelsteen GP; Kersten GF
    Vaccine; 2008 May; 26(19):2389-97. PubMed ID: 18406021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral protein complexed liposomes for intranasal delivery of hepatitis B surface antigen.
    Tiwari S; Verma SK; Agrawal GP; Vyas SP
    Int J Pharm; 2011 Jul; 413(1-2):211-9. PubMed ID: 21540094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
    Maa YF; Zhao L; Payne LG; Chen D
    J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation.
    Goyal AK; Rawat A; Mahor S; Gupta PN; Khatri K; Vyas SP
    Int J Pharm; 2006 Feb; 309(1-2):227-33. PubMed ID: 16406404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enhancement of a hepatitis B DNA vaccine potency using aluminum phosphate in mice].
    Liang ZW; Ren H; Lang YH; Li YG
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):79-81. PubMed ID: 14980105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A; Katare OP; Singh B; Vyas SP
    Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
    Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
    J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
    Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
    J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
    Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
    Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system.
    Jain V; Sahu R; Misra-Bhattacharya S; Vyas SP; Kohli D
    J Drug Target; 2008 Nov; 16(9):706-15. PubMed ID: 18982519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response induced by a different combined immunization of HBsAg vaccine.
    Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
    Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
    Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
    Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
    Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
    Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nanoparticles for the delivery of recombinant hepatitis B vaccine.
    Bharali DJ; Pradhan V; Elkin G; Qi W; Hutson A; Mousa SA; Thanavala Y
    Nanomedicine; 2008 Dec; 4(4):311-7. PubMed ID: 18640075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastic liposomes mediated transcutaneous immunization against Hepatitis B.
    Mishra D; Dubey V; Asthana A; Saraf DK; Jain NK
    Vaccine; 2006 May; 24(22):4847-55. PubMed ID: 16600441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.